体外膜肺氧合期间的抗凝
Anticoagulation during extracorporeal membrane oxygenation.
作者信息
Seelhammer Troy, Ninan Jacob, Nei Scott, Nabzdyk Christoph Gs, Wang Zhen, Gerberi Dana, Wieruszewski Patrick M
机构信息
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.
Department of Nephrology and Critical Care, MultiCare Capital Medical Center, Olympia, WA, USA.
出版信息
Cochrane Database Syst Rev. 2024 Jun 10;6(6):CD015685. doi: 10.1002/14651858.CD015685.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the efficacy and safety of anticoagulation for maintaining extracorporeal membrane oxygenation in people of all ages with cardiac or respiratory failure, or both.
摘要
这是一项Cochrane系统评价（干预措施）的方案。目标如下：确定抗凝治疗对维持患有心脏或呼吸衰竭或两者皆有的各年龄段人群体外膜肺氧合的有效性和安全性。
相似文献
1
Anticoagulation during extracorporeal membrane oxygenation.体外膜肺氧合期间的抗凝
Cochrane Database Syst Rev. 2024 Jun 10;6(6):CD015685. doi: 10.1002/14651858.CD015685.
2
Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1--overview of extracorporeal membrane oxygenation.体外膜肺氧合治疗成人重症心肺疾病：第1部分——体外膜肺氧合概述
J Cardiothorac Vasc Anesth. 2009 Dec;23(6):886-92. doi: 10.1053/j.jvca.2009.08.006.
3
Clinical use of venovenous extracorporeal membrane oxygenation.静脉-静脉体外膜肺氧合的临床应用
Hong Kong Med J. 2017 Apr;23(2):168-76. doi: 10.12809/hkmj166070. Epub 2017 Mar 17.
4
Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.用于呼吸衰竭的静脉-静脉体外膜肺氧合期间的抗凝实践。一项系统评价。
Ann Am Thorac Soc. 2016 Dec;13(12):2242-2250. doi: 10.1513/AnnalsATS.201605-364SR.
5
Hemostatic Management in Extracorporeal Membrane Oxygenation.体外膜肺氧合中的止血管理。
Crit Care Nurs Q. 2022;45(2):132-143. doi: 10.1097/CNQ.0000000000000396.
6
Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.需要静脉-静脉体外膜肺氧合的患者的抗凝策略比较：肝素与比伐卢定。
Crit Care Med. 2021 Jul 1;49(7):1129-1136. doi: 10.1097/CCM.0000000000004944.
7
Initial experience with single-vessel cannulation for venovenous extracorporeal membrane oxygenation in pediatric respiratory failure.小儿呼吸衰竭行单静脉插管建立体外膜肺氧合的初步经验。
Pediatr Crit Care Med. 2013 May;14(4):366-73. doi: 10.1097/PCC.0b013e31828a70dc.
8
Extracorporeal membrane oxygenation for critically ill adults.危重症成人的体外膜肺氧合
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010381. doi: 10.1002/14651858.CD010381.pub2.
9
Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.抗凝血酶浓缩剂在接受体外膜肺氧合治疗的儿童中的应用：一项回顾性队列研究。
Pediatr Crit Care Med. 2015 Mar;16(3):264-9. doi: 10.1097/PCC.0000000000000322.
10
A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.体外膜肺氧合期间补充抗凝血酶的随机对照试验。
Crit Care Med. 2020 Nov;48(11):1636-1644. doi: 10.1097/CCM.0000000000004590.
本文引用的文献
1
Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis.接受静脉-动脉体外膜肺氧合支持患者中活化部分凝血活酶时间（aPTT）引导的抗凝监测与血栓栓塞事件的关联：一项系统评价和荟萃分析
J Clin Med. 2023 Apr 30;12(9):3224. doi: 10.3390/jcm12093224.
2
Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: A systematic review.体外膜肺氧合支持的成人抗凝监测策略比较：系统评价。
Heart Lung. 2023 Sep-Oct;61:72-83. doi: 10.1016/j.hrtlng.2023.05.003. Epub 2023 May 9.
3
Current and future strategies to monitor and manage coagulation in ECMO patients.监测和管理体外膜肺氧合（ECMO）患者凝血功能的当前及未来策略
Thromb J. 2023 Jan 26;21(1):11. doi: 10.1186/s12959-023-00452-z.
4
Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis.肝素化成人静脉-动脉体外膜肺氧合患者采用低和高活化部分凝血活酶时间目标治疗的结局：系统评价和荟萃分析。
Perfusion. 2024 Apr;39(3):525-535. doi: 10.1177/02676591221150880. Epub 2023 Jan 3.
5
Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation.体外膜肺氧合期间比伐卢定与肝素抗凝作用的比较
ASAIO J. 2023 Apr 1;69(4):396-401. doi: 10.1097/MAT.0000000000001814. Epub 2022 Apr 10.
6
Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.体外膜肺氧合支持下的重症 COVID-19 患者的出血和血栓事件：一项全国性队列研究。
Intensive Care Med. 2022 Aug;48(8):1039-1052. doi: 10.1007/s00134-022-06794-y. Epub 2022 Jul 13.
7
Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.在需要静脉-动脉体外膜肺氧合的心源性休克患者中，比伐芦定与普通肝素的比较。
ASAIO J. 2023 Jan 1;69(1):107-113. doi: 10.1097/MAT.0000000000001723. Epub 2022 Apr 11.
8
Longitudinal Trends in Bleeding Complications on Extracorporeal Life Support Over the Past Two Decades-Extracorporeal Life Support Organization Registry Analysis.过去二十年体外生命支持中出血并发症的纵向趋势——体外生命支持组织登记分析。
Crit Care Med. 2022 Jun 1;50(6):e569-e580. doi: 10.1097/CCM.0000000000005466. Epub 2022 Feb 3.
9
Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.比伐芦定是否为体外膜肺氧合（ECMO）患者的替代抗凝剂？一项系统评价和荟萃分析。
Thromb Res. 2022 Feb;210:53-62. doi: 10.1016/j.thromres.2021.12.024. Epub 2021 Dec 31.
10
Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.比伐卢定与普通肝素在体外膜肺氧合成人患者抗凝中的比较。
ASAIO J. 2022 Jul 1;68(7):920-924. doi: 10.1097/MAT.0000000000001598. Epub 2022 Oct 19.
Zotero 插件